Cargando…
A view on EGFR-targeted therapies from the oncogene-addiction perspective
Tumor cell growth and survival can often be impaired by inactivating a single oncogen– a phenomenon that has been called as “oncogene addiction.” It is in such scenarios that molecular targeted therapies may succeed. among known oncogenes, the epidermal growth factor receptor (EGFR) has become the t...
Autores principales: | Perez, Rolando, Crombet, Tania, de Leon, Joel, Moreno, Ernesto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636470/ https://www.ncbi.nlm.nih.gov/pubmed/23637683 http://dx.doi.org/10.3389/fphar.2013.00053 |
Ejemplares similares
-
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
por: Perez, Rolando, et al.
Publicado: (2011) -
Targeting Non-Oncogene Addiction for Cancer Therapy
por: Chang, Hae Ryung, et al.
Publicado: (2021) -
Drugging the addict: non‐oncogene addiction as a target for cancer therapy
por: Nagel, Remco, et al.
Publicado: (2016) -
The Application of Inorganic Nanoparticles in Molecular Targeted Cancer Therapy: EGFR Targeting
por: Sun, Meng, et al.
Publicado: (2021) -
Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy
por: Concha-Benavente, Fernando, et al.
Publicado: (2017)